Navigation Links
Scotland to produce lifesaving HIV technology
Date:4/4/2013

NEW YORK, April 4, 2013 /PRNewswire/ -- Massachusetts-based life science company Daktari Diagnostics Inc. has announced plans to locate its global manufacturing base in Inverness, Scotland, to develop its life-saving HIV blood monitoring technology.

First Minister Alex Salmond will meet with Daktari Chief Executive Bill Rodriguez in New York today as part of his Scotland Week program aimed at encouraging inward investment.

Daktari has been in discussions with Highlands and Islands (HIE) and Scottish Development International (SDI), the country's international economic development organization, about plans to locate the production of its groundbreaking technology in Scotland.

Funding is in place to create 126 jobs, and the company's presence will build on the region's growing expertise in research, development and production in the life sciences sector.

Daktari, which employs 40 staff from its base in Cambridge, Mass., develops diagnostic tests for global health conditions such as HIV, hepatitis and tuberculosis. The company's Scottish venture could see mass production of blood testing cartridges required for CD4 cell counting, a process used in HIV monitoring, as early as next year. The system is currently undergoing clinical trials in Africa.

The $15 million project is being supported by HIE and SDI with a $3 million public sector package for relocation and workforce training.

First Minister, Alex Salmond , said:

"Scotland has the most comprehensive national life sciences strategy in the world and the sector continues to go from strength to strength. I am delighted to be meeting with Daktari as part of my Scotland Week program and confirm that 126 high value jobs are coming to Inverness.

"Daktari's intention to locate its manufacturing base in Scotland is a testament to our increasing reputation as a growing life sciences community and as the ideal place to invest and do business.

"They have been attracted to the Highlands and Islands to join an internationally renowned cluster of activity, and add to a growing Scottish life sciences sector which is worth more than $4 billion to the economy annually.

"This much welcomed decision by Daktari to base its production hub in the Inverness area is another example of how the quality and skills of the Scottish workforce are being recognized by world-leading companies and reinforces Scotland's reputation for excellence in innovation and manufacturing."

Bill Rodriguez , MD, President and CEO of Daktari Diagnostics Inc., commented:

"Daktari is excited about our new CD4 count, point-of-care, portable diagnostic product for HIV patients. Inverness, Scotland, offers companies like ours considerable support and a great location, with a highly educated work force and an ability to expand rapidly to support the demand for our new product.

"Designed to monitor patients in remote clinics anywhere in the world, the battery-powered Daktari CD4 counter provides the ease of use and low cost needed by many developing and emerging countries around the world. We believe Daktari is well positioned to capture significant market share in the coming years."

Danny Cusick , President, Americas, of Scottish Development International remarked:

"Scotland has a long tradition of innovation—pioneering the MRI and CAT scanners, the discovery of p53 cancer suppressor gene, the cloning of 'Dolly' the sheep and most recently, the potential cure for blindness.

"We have worked closely with Daktari to support their decision to join Scotland's thriving life sciences industry, which currently employs more than 32,000 people.

"Working alongside our partners at Highlands and Islands Enterprise, we will continue to garner global investors with a ambitious growth plans to invest in Scotland. We hope Daktari's investment leads to even more partnerships between the U.S. and Scotland's life sciences sectors and in turn, more life saving discoveries."

Media Contact: Jordan Robinson Agnor , jordan.robinson@aboutdci.com, (212) 725-0707


'/>"/>
SOURCE Scottish Development International
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. From Cloning Dolly the Sheep to Curing Blindness, Scotland is on the Forefront of Life Science Discoveries
2. Canada-based Radimetrics Announces Expansion to Scotland
3. Scotland-based Innova Partnerships Ltd. Opens Boston Office
4. COPAN Produces CDC/Joint Commission Educational Specimen Collection Videos
5. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
6. New Stroke Drug from ZZ Biotech Produced by Laureate Biopharma
7. JHP Pharmaceuticals to Produce Lyophilized Biologic for International Late-Phase Clinical Trials
8. Producer Austin Chapman Reaches Millions with Inspiring Story on Hearing Loss; Launches Contest in Partnership with Phonak
9. Yulex Corporation and Four D Rubber Co Ltd Partner to Produce First Guayule-Based, Allergy-Friendly Dental Dams
10. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
11. China Biologics Guizhou Taibang Subsidiary Donates Lifesaving Plasma Products for the Injured in the Yunnan Earthquake
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Pennsylvania Physician ... of Drug and Alcohol Programs Gary Tennis ... insomnia medications, known as benzodiazepines, developed with the ... "Benzodiazepines are medications that are frequently prescribed for ... they are used with opioid pain medications, benzodiazepines ...
(Date:12/8/2016)... 2016  A new study by a pair of ... opioid therapy to treat chronic pain is not only ... harmful consequences, including death. Palliative care physicians ... Mehta , M.D., authored the study which provides a ... The study was published in the December 2016 edition ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) aired ... of 2016. The program was made possible by a Pennsylvania Department of Health ... and Human Services Administration. The broadcast, Use Your Head: Properly Managing Sport ...
(Date:12/8/2016)... ... 2016 , ... The Florida Hospital Tampa Wound Healing Institute ... (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the Institute as ... facilities have earned this distinction. This is the second time the Florida Hospital ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... and JENNERSVILLE, Pa. (PRWEB) , ... December 08, ... ... that Penn Medicine Southern Chester County, a Property owned by an affiliate of ... million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
Breaking Medicine News(10 mins):